Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma

S. M. Whitcup, V. Stark-Vancs, R. E. Wittes, D. Solomon, M. J. Podgor, R. B. Nussenblatt and C. C. Chan
National Eye Institute, National Institutes of Health, Bethesda, Md., USA.

BACKGROUND: Diagnosis of primary central nervous system lymphoma (PCNSL) is usually made by identifying malignant lymphocytes in the brain, cerebrospinal fluid (CSF), or vitreous. However, these cells are few and friable, and misdiagnosis can occur, even in properly prepared specimens. Recent data suggest that levels of interleukin 10 (IL-10) are elevated in the serum and vitreous of patients with non-Hodgkin lymphoma; levels of interleukin 6 (IL-6) are elevated in the vitreous of patients with intraocular inflammation unrelated to a malignant neoplasm. We investigated whether PCNSL involving the vitreous or CSF is associated with elevated ratios of IL-10 to IL-6. PATIENTS: Vitreous specimens were obtained from 5 patients with PCNSL involving the eye and from 13 control patients with intraocular inflammation not related to a malignant neoplasm; CSF specimens were obtained from 11 patients with PCNSL. RESULTS: Levels of IL-10 exceeded those of IL-6 in all 5 patients with intraocular lymphoma but in none of the 13 patients with uveitis (P < .001). In patients with PCNSL, levels of IL-10 exceeded those of IL-6 in 6 of 11 CSF samples with malignant cells compared with 7 of 53 samples without malignant cells (P = .01). The calculated odds ratio (OR) suggests that the risk for malignant involvement of the CSF is about 8 times higher when IL-10 levels exceed IL-6 levels. METHODS: Levels of IL-10 and IL-6 were determined by enzyme-linked immunosorbent assay in both vitreous and CSF specimens. CONCLUSIONS: The occurrence of PCNSL in the eye was strongly associated with elevated vitreous levels of IL-10 relative to levels of IL-6. Moreover, among patients with diagnosed PCNSL, malignant cells were significantly more likely to be present in CSF when levels of IL-10 exceeded those of IL-6.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience
Frenkel et al.
Br. J. Ophthalmol. 2008;92:383-388.
ABSTRACT | FULL TEXT  

IL-10 Measurement in Aqueous Humor for Screening Patients with Suspicion of Primary Intraocular Lymphoma
Cassoux et al.
IOVS 2007;48:3253-3259.
ABSTRACT | FULL TEXT  

Protocol for the Use of Polymerase Chain Reaction in the Detection of Intraocular Large B-Cell Lymphoma in Ocular Samples
Lobo et al.
J. Mol. Diagn. 2007;9:113-121.
ABSTRACT | FULL TEXT  

Eradication of Tumor Colonization and Invasion by a B Cell-Specific Immunotoxin in a Murine Model for Human Primary Intraocular Lymphoma
Li et al.
Cancer Res. 2006;66:10586-10593.
ABSTRACT | FULL TEXT  

Primary Intraocular Lymphoma With a Low Interleukin 10 to Interleukin 6 Ratio and Heterogeneous IgH Gene Arrangement
Akpek et al.
Arch Ophthalmol 2000;118:731-732.
FULL TEXT  

Improving the Diagnostic Yield of Vitrectomy for Intraocular Lymphoma
Whitcup et al.
Arch Ophthalmol 2000;118:446-446.
FULL TEXT  

Using Interleukin 10 to Interleukin 6 Ratio to Distinguish Primary Intraocular Lymphoma and Uveitis
Buggage et al.
IOVS 1999;40:2462-2463.
FULL TEXT  

Primary Intraocular Lymphoma With a Low Interleukin 10 to Interleukin 6 Ratio and Heterogeneous IgH Gene Rearrangement
Buggage et al.
Arch Ophthalmol 1999;117:1239-1242.
ABSTRACT | FULL TEXT  

Detection of Human Herpesvirus-8 and Epstein-Barr Virus DNA in Primary Intraocular Lymphomas
Chan et al.
Blood 1999;93:2749-2751.
FULL TEXT